US › Healthcare

Surgery Partners Inc (SGRY)

US · Healthcare · Medical Care Facilities

$15.65-2.55%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$810.9M
Revenue YoY
+4.5%
Net profit
$-35.9M
Profit YoY
+4.8%
EPS
$-0.03
EPS estimate
$-0.14
Net margin
-4.4%

EPS came in at -0.03 against a street estimate of -0.14 — a beat of 78.6%.

Key statistics

Market cap
$2.10B
Forward P/E
22.3
P/B
1.19
Book value
$13.03
EPS (TTM)
$-0.59
52-week high
$24.10
52-week low
$11.41
50-day MA
$15.13
200-day MA
$15.46
Beta
1.94

Analyst view

Analysts rate Surgery Partners Inc a buy (9 buy, 3 hold, 0 sell out of 12) with an average price target of $18.64.

Shareholding

Insiders
1.79%
Institutions
123.26%

Largest institutional holders

FundStake
Bain Capital Investors LLC38.19%
HHG PLC10.35%
Pentwater Capital Management LP9.68%
King Street Capital Management LP7.82%
UBS Group AG7.79%
Vanguard Group Inc5.78%
BlackRock Inc4.33%
Dimensional Fund Advisors, Inc.4.05%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Surgery Partners Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.